The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
300 jobs Number of planned job creations
Announcement Date
23 April 2025
Employment effect (start)
23 May 2025
Foreseen end date
31 December 2025
Description
Sanofi, a French multinational pharmaceutical group, has announced the establishment of a new innovation hub in Barcelona's 22@ district, set to create over 300 highly qualified jobs in fields such as data science, artificial intelligence, and digital product development. The facility, expected to be operational by the end of 2025, will strengthen Barcelona’s position as a leading centre for health innovation.
This move is seen as a strategy to attract top talent in a competitive global market. The decision aligns with broader efforts to diversify Barcelona’s economy and consolidate its health ecosystem.
Previous job expansion processes of Sanofi in Spain were recorded in 2021, with the creation of 100 new jobs Sanofi 2021-ES
Eurofound (2025), Sanofi, Business expansion in Spain, factsheet number 202779, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/202779.